AKT1 and prostate carcinoma: Indeed, inconsistent with the strong downregulation of Igfbp2 mRNA that we observed in the liver of LPTENKO mice, PTEN was shown to inhibit IGFBP2 expression, while PI3K/AKT activation increases its expression in human brain and prostate cancer [112].